Efficacy of calcium supplementation for human bone health by mass spectrometry profiling and cathepsin K measurement in plasma samples.
Study Goal
The researchers aimed to compare the effects of different calcium sources on osteoporosis biomarkers using mass spectrometry and cathepsin K measurements.
Results Summary
The study found that different calcium sources influenced specific ion peaks in mass spectrometry, with calcium carbonate chew uniquely inhibiting cathepsin K, suggesting it may be more effective for osteoporosis prevention. Other calcium sources also modulated distinct protein fragments related to bone health.
Population
Older individuals, particularly postmenopausal women.
Effective Dosage
Not specified
Duration
Not specified
Interactions
None mentioned
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
calcium supplementation | decrease | occurrence of osteoporosis | older people, especially postmenopausal women | - | effective in decreasing | #1 |
different calcium supplement interventions | neutral | characteristic ion peaks | subjects | - | dMS detected characteristic ion peaks after | #2 |
all three treatments | decrease | ion peak 4281.0 m/z | subjects | - | commonly inhibited | #3 |
calcium carbonate chew | increase | ion peak 1786.5 m/z | subjects | - | upregulated after | #4 |
milk drink | increase | ion peak 3504.7 m/z | subjects | - | upregulated after | #5 |
milk mineral chew | decrease | ion peak 3359.6 m/z | subjects | - | downregulated after | #6 |
calcium carbonate chew treatment | decrease | cathepsin K | subjects | - | significantly inhibited | #7 |
Osteoporosis is a common disease among older people, especially postmenopausal women. Calcium supplementation is effective in decreasing the occurrence of osteoporosis. We tested the effect of different calcium sources (i.e., calcium carbonate chew, milk mineral chew, milk drink and placebo chew) by direct mass spectrometry (dMS) profiling and cathepsin K measurement in the serum of subjects. The dMS method is promising for plasma biomarker discovery, and cathepsin K level in the plasma is an indicator for osteoporosis. Our result shows that dMS detected characteristic ion peaks after different calcium supplement interventions; ion peak 4281.0 m/z was commonly inhibited by all three treatments. This ion peak was identified to be a fragment of follistatin-related protein 3 precursor by means of the "Lift" mode of MS/MS. The other differential ion peaks were also successfully identified: 1786.5 m/z (upregulated after calcium carbonate chew) was shown to be one fragment of transcription factor jun-B; the parent protein of 3504.7 m/z (upregulated after milk drink) was a collagen alpha-2 (type I) chain precursor; the ion peak of 3359.6 m/z (downregulated after milk mineral chew) was one fragment of family 31 glucosidase. Cathepsin K is significantly inhibited only by calcium carbonate chew treatment, indicating this form of calcium supplement has some advantage over other sources of supplementation.